Alcon has announced its financial results for the three- and twelve-month periods ending December 31, 2025. For the fourth quarter of 2025, sales were $2.7 billion, up 9 percent on a reported basis and up 7 percent on a constant currency basis, compared with the same quarter of the previous year. Reported net sales for the full-year 2025 were $10.3 billion, up 5 percent compared with full-year 2024. Excluding favorable currency impacts of 1 percent, sales were up 4 percent on a constant currency basis, the announcement said. Net sales for contact lenses within the Vision Care segment were $683 million in Q4, an increase of 7 percent. This growth was led by price increases and product innovation, partially offset by declines in legacy products, the company said.  Alcon’s Ceo David J. Endicott said: “2025 was a pivotal and productive year for Alcon. Despite softer markets, we successfully launched a wave of innovative new products that fueled sales acceleration as the year progressed. As we look to 2026, we’re encouraged by the momentum we’re carrying into the year and confident in our ability to continue to deliver sustainable growth and long-term value.”

March 2026